Corporation
McKesson Canada
- Meetings this Parliament
- 24
- With MPs
- 9
- Since Nov 2021
- 45
- Active registrations
- 1
Most recent reported meeting: Aug 4, 2026.
Lobbying by McKesson Canada: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
In-house (corporation) In effect since Feb 2, 2026
Filed by Dimitris Polygenis, President
Lobbyists
- Anthony Leong · Vice President, Public Policy & Government Affairs
- David Veillette · Vice President, Government Affairs QC & Atlantic Canada
- Jharna Bajaj · Sr Mgr, Government Relations
Institutions they may lobby: Competition Bureau Canada (COBU), Employment and Social Development Canada (ESDC), Environment and Climate Change Canada (ECCC), Finance Canada (FIN), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Indigenous Services Canada (ISC), Innovation, Science and Economic Development Canada (ISED), Intergovernmental Affairs Secretariat (IGA), Justice Canada (JC), Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Health Agency of Canada (PHAC), Public Safety Canada (PS), Public Services and Procurement Canada (PSPC), Treasury Board Of Canada Secretariat (TBS)
What they're lobbying on (11)Hide details
- How AI, automation, and healthcare data interoperability can support patient care throughout the healthcare system, particularly in the pharmacy and pharmaceutical distribution sectors
- Policies and programs aimed at red tape reduction to reduce regulatory burdens and timelines in the pharmaceutical distribution and associated sectors
- Offer recommendations on the Patented Medicines Pricing Review Board excessive pricing policy guidelines and implementation approaches to support drug supply stability and system sustainability
- Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs
- Medical cannabis policy impacts on pharmacy and the wholesale industry
- Health Canada, with respect to the role of wholesalers in the management of drug shortages
- Health Canada, with respect to the regulation and funding of wholesale distribution of pharmaceuticals and regulation of pharmacy activities
- Health Canada, with respect to pandemic planning, particularly federal/provincial/territorial storage and distribution of pharmaceuticals
- Development of screening programs in First Nations communities
- Approaches towards National Pharmacare policy
- Approaches to mitigating the impact of COVID-19 on the pharmaceutical distribution, pharmacy, primary care, and other healthcare sectors
Registration 962320-263742-42. Look it up in the official Registry
Reported meetings
SpreadsheetFiled by Joan Eliasek (29), Dimitris Polygenis (15), Rebecca McKillican (1).
-
Reported by Joan Eliasek · In-house (corporation)
- Bryce McRae · Manager of Stakeholder Relations, House of Commons
Health Canada, with respect to the role of wholesalers in the management of drug shortages
-
Reported by Joan Eliasek · In-house (corporation)
- Pierre Poilievre · Member of Parliament
- Matthew Antonitti · Chief of Operations, House of Commons
Health Canada, with respect to the role of wholesalers in the management of drug shortages
-
Reported by Joan Eliasek · In-house (corporation)
- Sonia Sidhu · MP Brampton South
Health Canada, with respect to the role of wholesalers in the management of drug shortages Read more
Approaches towards National Pharmacare policy
-
Reported by Joan Eliasek · In-house (corporation)
- Ian Foucher · Chief of Staff, Innovation, Science and Economic Development Canada (ISED)
Health
-
Reported by Joan Eliasek · In-house (corporation)
- Cyndi Jenkins · Chief of Staff, Health Canada (HC)
Health
-
Reported by Joan Eliasek · In-house (corporation)
- Dani Saad · Senior Policy Advisor, Prime Minister's Office (PMO)
Health
-
Reported by Joan Eliasek · In-house (corporation)
- Marc Holland · Minister, Health Canada (HC)
Health
-
Reported by Joan Eliasek · In-house (corporation)
- Ginette Petitpas Taylor · Minister, Veterans Affairs Canada (VAC)
Health
-
Reported by Joan Eliasek · In-house (corporation)
- Jean-Sebastian Bock · Deputy Chief of Staff and Director of Policy, Health Canada (HC)
Health
-
Reported by Joan Eliasek · In-house (corporation)
- Adam Chambers · MP Simcoe North, Health Canada (HC)
Health
-
Reported by Joan Eliasek · In-house (corporation)
- Luc Thériault · MP Montcalm
Health
-
Reported by Joan Eliasek · In-house (corporation)
- Laurel Lennox · Advisor Issues Management & Communications, Innovation, Science and Economic Development Canada (ISED)
Health
-
Reported by Joan Eliasek · In-house (corporation)
- Laurence Lefevre · QC Desk Policy Advisor, Health Canada (HC)
Health
-
Reported by Joan Eliasek · In-house (corporation)
- Philip Proulx · ED and Quebect Desk Director at the Prime Minister's Office, Health Canada (HC)
- John Ophelia · Sr Policy Advisory, Office of the Health Minister, Health Canada (HC)
Health
-
Reported by Joan Eliasek · In-house (corporation)
- Jean-Sebastien Bock · Deputy Chief of Staff and Director of Policy, Health Canada (HC)
- Jade Maillette · Director of Parliamentary Affairs, Health Canada (HC)
Health
-
Reported by Joan Eliasek · In-house (corporation)
- Jean-Sebastien Bock · Deputy Chief of Staff and Director of Policy, Health Canada (HC)
- Jade Mailette · Director of Parliamentary Affairs, Health Canada (HC)
Health
-
Reported by Joan Eliasek · In-house (corporation)
- Stephen Ellis · Member of Parliament for Cumberland-Colchester and Conservative Health Critic, House of Commons
Health
-
Reported by Joan Eliasek · In-house (corporation)
- Simon Kennedy · DM, Innovation, Science and Economic Development Canada (ISED)
Health
-
Reported by Joan Eliasek · In-house (corporation)
- Stephen Ellis · Member of Parliament, House of Commons
Health
-
Reported by Rebecca McKillican · In-house (corporation)
- Jamie Kippen · Chief of Staff, Health Canada (HC)
- Jean-Sebastien Bock · Director of Policy, Health Canada (HC)
- Sandenga Yeba · Senior Policy Advisor to the Minister, Health Canada (HC)
Health
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.